|
EXOSC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.319200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.827800E-01 |
| Normal-vs-Stage2 |
5.681600E-01 |
| Normal-vs-Stage3 |
2.227200E-01 |
| Normal-vs-Stage4 |
3.224400E-01 |
| Stage1-vs-Stage2 |
8.595200E-01 |
| Stage1-vs-Stage3 |
4.650400E-02 |
| Stage1-vs-Stage4 |
6.729500E-02 |
| Stage2-vs-Stage3 |
1.695040E-01 |
| Stage2-vs-Stage4 |
2.082600E-01 |
| Stage3-vs-Stage4 |
9.214200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.345000E-01 |
| Normal-vs-AfricanAmerican |
6.224800E-01 |
| Normal-vs-Asian |
7.115000E-01 |
| Caucasian-vs-AfricanAmerican |
4.511400E-01 |
| Caucasian-vs-Asian |
6.484200E-01 |
| AfricanAmerican-vs-Asian |
6.291600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.767800E-01 |
| Normal-vs-Female |
2.458400E-01 |
| Male-vs-Female |
8.924100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.456800E-01 |
| Normal-vs-Extreme_Weight |
4.807600E-01 |
| Normal-vs-Obese |
9.171200E-01 |
| Normal-vs-Extreme_Obese |
8.649000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.790400E-01 |
| Normal_Weight-vs-Obese |
8.810600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.924200E-01 |
| Extreme_Weight-vs-Obese |
4.805600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.657000E-01 |
| Obese-vs-Extreme_Obese |
8.431400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.678020E-01 |
| Normal-vs-Age(41-60Yrs) |
7.733800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.936000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.305600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.896240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.324760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.743700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.579800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.533000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.603600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.281200E-01 |
| Normal-VS-Type2 PRCC |
4.172400E-01 |
| Normal-VS-KIRP CIMP |
1.358190E-02 |
| Normal-VS-Unclassified PRCC |
6.456000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.945600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.132060E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.419800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.400200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.370800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.022020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.820200E-01 |
| Normal-vs-N1 |
4.957700E-02 |
| Normal-vs-N2 |
8.823800E-02 |
| N0-vs-N1 |
2.888000E-02 |
| N0-vs-N2 |
3.618000E-01 |
| N1-vs-N2 |
1.614630E-01 |
|
|
